Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety

Andrew S. Felts; Alice L. Rodriguez; Ryan D. Morrison; Daryl F. Venable; Jason T. Manka; Brittney S. Bates; Anna L. Blobaum; Frank W. Byers; J. Scott Daniels; Colleen M. Niswender; Carrie K. Jones; P. Jeffrey Conn; Craig W. Lindsley; Kyle A. Emmitte

doi:10.1016/j.bmcl.2013.09.001

Discovery of VU0409106: A negative allosteric modulator of mGlu₅ with activity in a mouse model of anxiety

Andrew S. Felts, Alice L. Rodriguez, Ryan D. Morrison, Daryl F. Venable, Jason T. Manka, Brittney S. Bates, Anna L. Blobaum, Frank W. Byers, J. Scott Daniels, Colleen M. Niswender, Carrie K. Jones, P. Jeffrey Conn, Craig W. Lindsley, Kyle A. Emmitte

Research output: Contribution to journal › Article

24 Scopus citations

Abstract

Development of SAR in an aryl ether series of mGlu₅ NAMs leading to the identification of tool compound VU0409106 is described in this Letter. VU0409106 is a potent and selective negative allosteric modulator of mGlu ₅ that binds at the known allosteric binding site and demonstrates good CNS exposure following intraperitoneal dosing in mice. VU0409106 also proved efficacious in a mouse marble burying model of anxiety, an assay known to be sensitive to mGlu₅ antagonists as well as clinically efficacious anxiolytics.

Original language	English
Pages (from-to)	5779-5785
Number of pages	7
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	23
Issue number	21
DOIs	https://doi.org/10.1016/j.bmcl.2013.09.001
State	Published - 1 Nov 2013

Keywords

Allosteric modulator
Anxiety
CNS
Glutamate
mGlu

Access to Document

10.1016/j.bmcl.2013.09.001

Link to publication in Scopus

Fingerprint Dive into the research topics of 'Discovery of VU0409106: A negative allosteric modulator of mGlu<sub>5</sub> with activity in a mouse model of anxiety'. Together they form a unique fingerprint.

Cite this

Felts, A. S., Rodriguez, A. L., Morrison, R. D., Venable, D. F., Manka, J. T., Bates, B. S., Blobaum, A. L., Byers, F. W., Daniels, J. S., Niswender, C. M., Jones, C. K., Conn, P. J., Lindsley, C. W., & Emmitte, K. A. (2013). Discovery of VU0409106: A negative allosteric modulator of mGlu₅ with activity in a mouse model of anxiety. Bioorganic and Medicinal Chemistry Letters, 23(21), 5779-5785. https://doi.org/10.1016/j.bmcl.2013.09.001

Felts, Andrew S. ; Rodriguez, Alice L. ; Morrison, Ryan D. ; Venable, Daryl F. ; Manka, Jason T. ; Bates, Brittney S. ; Blobaum, Anna L. ; Byers, Frank W. ; Daniels, J. Scott ; Niswender, Colleen M. ; Jones, Carrie K. ; Conn, P. Jeffrey ; Lindsley, Craig W. ; Emmitte, Kyle A. / Discovery of VU0409106 : A negative allosteric modulator of mGlu₅ with activity in a mouse model of anxiety. In: Bioorganic and Medicinal Chemistry Letters. 2013 ; Vol. 23, No. 21. pp. 5779-5785.

@article{818079dcc5144a989615d0156696f0c5,

title = "Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety",

abstract = "Development of SAR in an aryl ether series of mGlu5 NAMs leading to the identification of tool compound VU0409106 is described in this Letter. VU0409106 is a potent and selective negative allosteric modulator of mGlu 5 that binds at the known allosteric binding site and demonstrates good CNS exposure following intraperitoneal dosing in mice. VU0409106 also proved efficacious in a mouse marble burying model of anxiety, an assay known to be sensitive to mGlu5 antagonists as well as clinically efficacious anxiolytics.",

keywords = "Allosteric modulator, Anxiety, CNS, Glutamate, mGlu",

author = "Felts, {Andrew S.} and Rodriguez, {Alice L.} and Morrison, {Ryan D.} and Venable, {Daryl F.} and Manka, {Jason T.} and Bates, {Brittney S.} and Blobaum, {Anna L.} and Byers, {Frank W.} and Daniels, {J. Scott} and Niswender, {Colleen M.} and Jones, {Carrie K.} and Conn, {P. Jeffrey} and Lindsley, {Craig W.} and Emmitte, {Kyle A.}",

year = "2013",

month = nov,

day = "1",

doi = "10.1016/j.bmcl.2013.09.001",

language = "English",

volume = "23",

pages = "5779--5785",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Ltd",

number = "21",

}

Felts, AS, Rodriguez, AL, Morrison, RD, Venable, DF, Manka, JT, Bates, BS, Blobaum, AL, Byers, FW, Daniels, JS, Niswender, CM, Jones, CK, Conn, PJ, Lindsley, CW & Emmitte, KA 2013, 'Discovery of VU0409106: A negative allosteric modulator of mGlu₅ with activity in a mouse model of anxiety', Bioorganic and Medicinal Chemistry Letters, vol. 23, no. 21, pp. 5779-5785. https://doi.org/10.1016/j.bmcl.2013.09.001

Discovery of VU0409106 : A negative allosteric modulator of mGlu₅ with activity in a mouse model of anxiety. / Felts, Andrew S.; Rodriguez, Alice L.; Morrison, Ryan D.; Venable, Daryl F.; Manka, Jason T.; Bates, Brittney S.; Blobaum, Anna L.; Byers, Frank W.; Daniels, J. Scott; Niswender, Colleen M.; Jones, Carrie K.; Conn, P. Jeffrey; Lindsley, Craig W.; Emmitte, Kyle A.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 23, No. 21, 01.11.2013, p. 5779-5785.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Discovery of VU0409106

T2 - A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety

AU - Felts, Andrew S.

AU - Rodriguez, Alice L.

AU - Morrison, Ryan D.

AU - Venable, Daryl F.

AU - Manka, Jason T.

AU - Bates, Brittney S.

AU - Blobaum, Anna L.

AU - Byers, Frank W.

AU - Daniels, J. Scott

AU - Niswender, Colleen M.

AU - Jones, Carrie K.

AU - Conn, P. Jeffrey

AU - Lindsley, Craig W.

AU - Emmitte, Kyle A.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Development of SAR in an aryl ether series of mGlu5 NAMs leading to the identification of tool compound VU0409106 is described in this Letter. VU0409106 is a potent and selective negative allosteric modulator of mGlu 5 that binds at the known allosteric binding site and demonstrates good CNS exposure following intraperitoneal dosing in mice. VU0409106 also proved efficacious in a mouse marble burying model of anxiety, an assay known to be sensitive to mGlu5 antagonists as well as clinically efficacious anxiolytics.

AB - Development of SAR in an aryl ether series of mGlu5 NAMs leading to the identification of tool compound VU0409106 is described in this Letter. VU0409106 is a potent and selective negative allosteric modulator of mGlu 5 that binds at the known allosteric binding site and demonstrates good CNS exposure following intraperitoneal dosing in mice. VU0409106 also proved efficacious in a mouse marble burying model of anxiety, an assay known to be sensitive to mGlu5 antagonists as well as clinically efficacious anxiolytics.

KW - Allosteric modulator

KW - Anxiety

KW - CNS

KW - Glutamate

KW - mGlu

UR - http://www.scopus.com/inward/record.url?scp=84885187910&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2013.09.001

DO - 10.1016/j.bmcl.2013.09.001

M3 - Article

C2 - 24074843

AN - SCOPUS:84885187910

VL - 23

SP - 5779

EP - 5785

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 21

ER -